Dare Bioscience, Inc.
DARE- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001401914
No open-market purchases or sales by Dare Bioscience, Inc. insiders were filed in the last 90 days; 27 institutions reported holding it in 13F filings for Q2 2026, worth $2.75M in total; no superinvestor holds it.
Q2 2021 vs. Q1 2021
How the institutions holding Dare Bioscience, Inc. changed between Q1 2021 and Q2 2021.
All holders in Q2 2021All holders in Q1 2021
| Measure | Q1 2021 | Q2 2021 | Change |
|---|---|---|---|
| Holders | 30 | 34 | +4 |
| Shares | 3.61M | 3.39M | −220.8K (−6.1%) |
| Value | $6.10M | $6.40M | +$302.0K (+5.0%) |
New holders (9)
Institutions that held Dare Bioscience, Inc. at the end of Q2 2021 but not at the end of Q1 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Morgan Stanley | 63,645 | $120.0K | 0.00% |
| State Street Corp | 62,630 | $118.0K | 0.00% |
| Two Sigma Securities, LLC | 44,394 | $84.0K | 0.02% |
| XTX Topco Ltd | 14,101 | $27.0K | 0.01% |
| Insight Financial Services | 11,400 | $21.0K | 0.01% |
| Paradigm, Strategies in Wealth Management, LLC | 10,000 | $19.0K | 0.02% |
| Bank of America Corp | 2,320 | $4.00K | 0.00% |
| American Portfolios Advisors | 1,000 | $1.89K | 0.00% |
| Royal Bank of Canada | 50 | $0 | 0.00% |
Sold out (5)
Institutions that held Dare Bioscience, Inc. at the end of Q1 2021 and filed for Q2 2021 without it.
| Institution | Shares, Q1 2021 | Value, Q1 2021 |
|---|---|---|
| Virtu Financial LLC | 149,593 | $253.0K |
| Squarepoint Ops LLC | 142,133 | $240.0K |
| Charles Schwab Investment Management Inc | 20,123 | $35.0K |
| ExodusPoint Capital Management, LP | 18,773 | $32.0K |
| Barclays PLC | 351 | $1.00K |